Related Experiment Videos
Type IV collagen in hypertrophic cardiomyopathy
K Ohsato1, M Shimizu, N Sugihara
1Second Department of Internal Medicine, School of Medicine, Kanazawa University, Japan.
Japanese Heart Journal
|May 1, 1994
Summary
Serum type IV collagen is elevated in hypertrophic cardiomyopathy (HCM) patients, correlating with functional abnormalities. Measuring this protein may aid in diagnosing myocardial basement membrane injury and tracking HCM progression.
Area of Science:
- Cardiology
- Biochemistry
- Pathology
Background:
- Myocardial basement membrane integrity is crucial for cardiac function.
- Discontinuities in the basement membrane of myocytes have been observed in hypertrophic cardiomyopathy (HCM).
Purpose of the Study:
- To determine serum type IV collagen levels in HCM patients.
- To investigate the relationship between serum type IV collagen and functional abnormalities in HCM.
Main Methods:
- Utilized a sandwich immunoassay technique.
- Analyzed serum samples from 31 HCM patients and controls.
- Correlated serum type IV collagen levels with echocardiographic parameters like fractional shortening and end-diastolic volume.
Main Results:
- Significantly increased serum type IV collagen levels were found in HCM patients compared to controls.
- Serum type IV collagen showed significant correlations with fractional shortening (r = -0.42), end-diastolic volume (r = 0.40), and deceleration time (DT) (r = -0.50).
Conclusions:
- Elevated serum type IV collagen may reflect alterations in the myocardial basement membrane and cytoskeleton in HCM.
- Serum type IV collagen measurement is a potential diagnostic tool for myocardial basement membrane injury and monitoring HCM progression.